The present invention provides a method to manufacture panfungal T-cell products with specificity against a range of clinical fungal pathogens by use of the blood and stem cells of healthy donors as the starting material. Specifically, the combination of T cells stimulated by lysates of Aspergillus terreus and Candida krusei provides a broadly cross-reactive T cell population. In another embodiment, lysate of Rhizopus oryzae are also used.
